Neely Mozaffarian, M.D., Ph.D.

Neely Mozaffarian, M.D., Ph.D.

CMO, Head of Development @ Ouro Medicines

About

Pharmaceutical R&D, Autoimmune/inflammatory Diseases, Immune Homeostasis, Pain Therapies, Phases 1 - 4 M.D., Rheumatology, Internal Medicine Ph.D., Microbiology and Immunology

Country

United States

City

Seattle

Industry

Pharmaceuticals

Skill

Board of Directors, Team Building, Strategic Leadership, Board Governance, Leadership, Orphan Drugs, Medical Education, Strategic Thinking, Business Strategy, Immunology, Rheumatology, Clinical Development, Internal Medicine, Pharmaceutical Industry, Medicine, Clinical Trials, Drug Development, GCP, Medical Affairs, Inflammation

Experience

Ouro Medicines

CMO, Head of Development

Ouro Medicines

LinkedIn
2024-11 - Present · 1 yr 11 mos
Rheumatology Frontiers in Medicine

Journal Review Editor

Rheumatology Frontiers in Medicine

2022-10 - Present · 4 yrs
Fate Therapeutics Inc.

Board of Directors, Independent Member

Fate Therapeutics Inc.

LinkedIn
2024-7 - 2025-10 · 1 yr 4 mos
Atomwise

CMO, Head of Development

Atomwise

LinkedIn
2023-9 - 2024-11 · 1 yr 3 mos

United States

GentiBio

CMO, Head of Development

GentiBio

LinkedIn
2022-5 - 2023-9 · 1 yr 5 mos

Cambridge, Massachusetts, United States

Johnson & Johnson Innovative Medicine

Vice President, Autoantibody Pathway Area Leader

Johnson & Johnson Innovative Medicine

LinkedIn
2021-4 - 2022-5 · 1 yr 2 mos
Ichnos Sciences

Senior VP, Head of Clinical Development

Ichnos Sciences

2019-5 - 2021-4 · 2 yrs

Greater New York City Area

Gilead Sciences

Executive Director, Group Leader Rheumatology/Autoimmunity Global Clinical Development

Gilead Sciences

LinkedIn
2016-4 - 2019-3 · 3 yrs

Foster City, CA

Group Leader Global Clinical Development for Rheumatology/Autoimmunity Portfolio: small and large molecules Strategic leadership of Rheumatology/Autoimmunity Clinical Development Team Global studies Phases 1-4

Eli Lilly and Company

Senior Medical Director, Global Early Immunology Clinical Development

Eli Lilly and Company

LinkedIn
2013-5 - 2016-4 · 3 yrs

Lilly Biotechnology Center

Global Clinical Development for Early Immunology/Autoimmunity portfolio: Strategic leadership for Clinical Development Team and Clinical Operations through Phase 2b for biologics and small molecules globally

AbbVie

Medical Director, Global Clinical Development, HUMIRA and Early Immunology

AbbVie

LinkedIn
2009-12 - 2013-5 · 3 yrs 6 mos

AbbVie, Inc. (formerly Abbott Laboratories)

Immunology compounds/global clinical development in autoimmunity: biologics and small molecules Humira Global Clinical Development, Rheumatology Division

Education

Albert Einstein College of Medicine

Albert Einstein College of Medicine

LinkedIn

Medicine, Microbiology and Immunology

University of Washington

University of Washington

LinkedIn

Rheumatology Residency Program

University of Washington

University of Washington

LinkedIn

Internal Medicine Residency Program

Neely Mozaffarian, M.D., Ph.D.'s Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.